154 related articles for article (PubMed ID: 34625577)
1. SHP-2 deletion in CD4Cre expressing chondrocyte precursors leads to tumor development with wrist tropism.
McNamara JT; Huntington KE; Borys S; Jayasuriya CT; Brossay L
Sci Rep; 2021 Oct; 11(1):20006. PubMed ID: 34625577
[TBL] [Abstract][Full Text] [Related]
2.
Miah SMS; Jayasuriya CT; Salter AI; Reilly EC; Fugere C; Yang W; Chen Q; Brossay L
Front Immunol; 2017; 8():1326. PubMed ID: 29085371
[TBL] [Abstract][Full Text] [Related]
3. SHP2 regulates chondrocyte terminal differentiation, growth plate architecture and skeletal cell fates.
Bowen ME; Ayturk UM; Kurek KC; Yang W; Warman ML
PLoS Genet; 2014; 10(5):e1004364. PubMed ID: 24875294
[TBL] [Abstract][Full Text] [Related]
4. Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations.
Bauler TJ; Kamiya N; Lapinski PE; Langewisch E; Mishina Y; Wilkinson JE; Feng GS; King PD
Dis Model Mech; 2011 Mar; 4(2):228-39. PubMed ID: 21068439
[TBL] [Abstract][Full Text] [Related]
5. Impaired natural killing of MHC class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1.
Lowin-Kropf B; Kunz B; Beermann F; Held W
J Immunol; 2000 Aug; 165(3):1314-21. PubMed ID: 10903732
[TBL] [Abstract][Full Text] [Related]
6. The tyrosine phosphatase Shp-2 confers resistance to colonic inflammation by driving goblet cell function and crypt regeneration.
Gagné-Sansfacon J; Langlois A; Langlois MJ; Coulombe G; Tremblay S; Vaillancourt-Lavigueur V; Qu CK; Menendez A; Rivard N
J Pathol; 2019 Jan; 247(1):135-146. PubMed ID: 30376595
[TBL] [Abstract][Full Text] [Related]
7. Deletion of SHP-2 in mesenchymal stem cells causes growth retardation, limb and chest deformity, and calvarial defects in mice.
Lapinski PE; Meyer MF; Feng GS; Kamiya N; King PD
Dis Model Mech; 2013 Nov; 6(6):1448-58. PubMed ID: 24077964
[TBL] [Abstract][Full Text] [Related]
8. A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells.
Xu D; Wang S; Yu WM; Chan G; Araki T; Bunting KD; Neel BG; Qu CK
Blood; 2010 Nov; 116(18):3611-21. PubMed ID: 20651068
[TBL] [Abstract][Full Text] [Related]
9. The SH2 domain-containing protein tyrosine phosphatase SHP-1 is induced by granulocyte colony-stimulating factor (G-CSF) and modulates signaling from the G-CSF receptor.
Ward AC; Oomen SP; Smith L; Gits J; van Leeuwen D; Soede-Bobok AA; Erpelinck-Verschueren CA; Yi T; Touw IP
Leukemia; 2000 Jul; 14(7):1284-91. PubMed ID: 10914554
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphatase SHP-2 mediates C-type lectin receptor-induced activation of the kinase Syk and anti-fungal TH17 responses.
Deng Z; Ma S; Zhou H; Zang A; Fang Y; Li T; Shi H; Liu M; Du M; Taylor PR; Zhu HH; Chen J; Meng G; Li F; Chen C; Zhang Y; Jia XM; Lin X; Zhang X; Pearlman E; Li X; Feng GS; Xiao H
Nat Immunol; 2015 Jun; 16(6):642-52. PubMed ID: 25915733
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous chondroma formation in CD2-Cre-driven Erk-deficient mice.
Shiokawa M; Lu X; Miyake Y; Ishikawa E; Pagès G; Pouysségur J; Ogata M; Yamasaki S
Int Immunol; 2017 Dec; 29(10):479-485. PubMed ID: 29106539
[TBL] [Abstract][Full Text] [Related]
12. Regulation of bone and skeletal development by the SHP-2 protein tyrosine phosphatase.
Kamiya N; Kim HK; King PD
Bone; 2014 Dec; 69():55-60. PubMed ID: 25178522
[TBL] [Abstract][Full Text] [Related]
13. The tyrosine phosphatase SHP-1 dampens murine Th17 development.
Mauldin IS; Tung KS; Lorenz UM
Blood; 2012 May; 119(19):4419-29. PubMed ID: 22438258
[TBL] [Abstract][Full Text] [Related]
14. Involvement of the SHP-1 tyrosine phosphatase in regulation of T cell selection.
Zhang J; Somani AK; Yuen D; Yang Y; Love PE; Siminovitch KA
J Immunol; 1999 Sep; 163(6):3012-21. PubMed ID: 10477564
[TBL] [Abstract][Full Text] [Related]
15. Protein Tyrosine Phosphatase SHP-2 Is Involved in the Interleukin-21-Induced Activation of Extracellular Signal-Regulated Kinase 1/2.
Jin L; Nara H; Rahman M; Takeda Y; Araki A; Asao H
Tohoku J Exp Med; 2018 Mar; 244(3):187-193. PubMed ID: 29503347
[TBL] [Abstract][Full Text] [Related]
16. A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development.
Qu CK; Shi ZQ; Shen R; Tsai FY; Orkin SH; Feng GS
Mol Cell Biol; 1997 Sep; 17(9):5499-507. PubMed ID: 9271425
[TBL] [Abstract][Full Text] [Related]
17. Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase.
Somani AK; Bignon JS; Mills GB; Siminovitch KA; Branch DR
J Biol Chem; 1997 Aug; 272(34):21113-9. PubMed ID: 9261115
[TBL] [Abstract][Full Text] [Related]
18. Notch pathway regulation of chondrocyte differentiation and proliferation during appendicular and axial skeleton development.
Mead TJ; Yutzey KE
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14420-5. PubMed ID: 19590010
[TBL] [Abstract][Full Text] [Related]
19. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation.
Qu CK; Feng GS
Oncogene; 1998 Jul; 17(4):433-9. PubMed ID: 9696036
[TBL] [Abstract][Full Text] [Related]
20. Functional requirements for inhibitory signal transmission by the immunomodulatory receptor CD300a.
DeBell KE; Simhadri VR; Mariano JL; Borrego F
BMC Immunol; 2012 Apr; 13():23. PubMed ID: 22537350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
